Related Topics News - Drugs

     
 < Previous page   Title only   |   Print    Next page > 
     
聯邦制藥度普利尤單抗注射液獲臨床試驗默示許可

2026-04-22T  
綠葉製藥創新藥LY03015臨床試驗完成首例受試者入組

2026-04-20T  
綠葉製藥LY03017II期臨床試驗完成首例受試者入組

2026-04-15T  
國家醫保局:將著優化集採規則及強化結果落地實施等

2026-04-15T  
《大行》花旗降綠葉製藥目標價至4.3元 成熟產品降價影響較預期重

2026-04-14T  
綠葉製藥LY03020臨床試驗完成首例受試者入組

2026-04-09T  
《大行》美銀證券降微創醫療目標價至13.9元 重申「買入」評級

2026-04-08T  
《大行》摩通升微創機器人目標價至42元 評級「增持」

2026-04-08T  
《輪動華泰》油價再度走高 電車股留意獨家奇瑞購27386

2026-04-02T  
《業績》微創醫療全年純利4,852萬美元 虧轉盈

2026-04-01T  
 < Previous page    Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.